Adoptive T-cell therapies in the clinic

Area of Science:

• Immunology and Cellular Medicine
• Therapeutic Applications of Immune Cells

Background:

• T cells are crucial immune cells with high target specificity, making them ideal for precision therapies.
• T cell therapies are a leading frontier in cellular medicine, explored for oncology and autoimmune diseases.

Purpose of the Study:

• To provide a comprehensive overview of the clinical landscape of T cell therapies.
• To analyze historical developments, clinical translation, and regulatory approvals of T cell therapies.
• To identify trends, challenges, and future potential of T cell-based treatments.

Main Methods:

• Detailed review of historical milestones in T cell discovery.
• Analysis of 19 globally approved T cell therapy products and their features.
• In-depth analysis of 2570 clinical trials, evaluating parameters like cell source, indications, and targets.

Main Results:

• Identified three distinct growth intervals in T cell therapy clinical activity.
• Observed a higher rate of recent product approvals for T cell therapies compared to stem cell therapies.
• Highlighted emerging trends in trial parameters and key inflection points in clinical translation.

Conclusions:

• T cell therapies demonstrate steady growth in clinical studies and regulatory approvals.
• The evolution of T cell therapies is marked by phased growth driven by scientific advancements.
• Biological and logistical challenges remain for broader clinical translation to new indications and populations.